We are live on ! Find out more
AMRI

Albany Molecular Research Inc
AMRI

Delisted

AMRI was delisted on the 31st of August, 2017.

Back to rankings

113 hedge funds and large institutions have $515M invested in Albany Molecular Research Inc in 2014 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 37 increasing their positions, 36 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

144% more call options, than puts

Call options by funds: $6.15M | Put options by funds: $2.52M

95% more capital invested

Capital invested by funds: $264M → $515M (+$251M)

3% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 36

4% less funds holding

Funds holding: 118 → 113 (-5)

18% less first-time investments, than exits

New positions opened: 23 | Existing positions closed: 28

Holders
113
Holders Change
-5
Holders Change %
-4.24%
% of All Funds
3.26%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.06%
New
23
Increased
37
Reduced
36
Closed
28
Calls
$6.15M
Puts
$2.52M
Net Calls
+$3.63M
Net Calls Change
+$3.46M

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$13.3M
2
HM
HealthCor Management
New York
+$12.4M
3
DCM
Decade Capital Management
New York
+$8.95M
4
BIM
Bogle Investment Management
Massachusetts
+$7.21M
5
HVC
Healthcare Value Capital
New Jersey
+$6.17M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$15.9M
2
BIT
BlackRock Institutional Trust
California
-$8.91M
3
CS
Credit Suisse
Switzerland
-$2.47M
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$2.42M
5
SFM
Systematic Financial Management
New Jersey
-$1.73M
Name Holding Trade Value Shares
Change 		Change in
Stake
Asset Management One
51
Asset Management One
Japan
$1.1M – – –
WIC
52
Woodmont Investment Counsel
Tennessee
$1.08M -$717K -52,100 -47%
HK
53
Horizon Kinetics
New York
$1.04M – – –
Axa
54
Axa
France
$1.03M -$156K -11,300 -17%
CS
55
Credit Suisse
Switzerland
$1.02M -$2.47M -179,187 -76%
FQ
56
First Quadrant
California
$946K – – –
CCM
57
Cadence Capital Management
Massachusetts
$931K +$689K +50,060 New
MERSOM
58
Municipal Employees' Retirement System of Michigan
Michigan
$931K +$690K +50,100 New
SFM
59
Soros Fund Management
New York
$905K +$671K +48,700 New
ProShare Advisors
60
ProShare Advisors
Maryland
$887K +$442K +32,071 +205%
California State Teachers Retirement System (CalSTRS)
61
California State Teachers Retirement System (CalSTRS)
California
$787K +$4.13K +300 +0.7%
SO
62
STRS Ohio
Ohio
$786K -$397K -28,800 -41%
GCP
63
GSA Capital Partners
United Kingdom
$760K -$1.08M -78,111 -66%
FM
64
Forward Management
California
$717K +$669K +48,560 New
TA
65
Teachers Advisors
New York
$662K – – –
RhumbLine Advisers
66
RhumbLine Advisers
Massachusetts
$623K -$15.7K -1,140 -3%
Royal Bank of Canada
67
Royal Bank of Canada
Ontario, Canada
$617K +$22.6K +1,640 +5%
LCS
68
Levin Capital Strategies
New York
$597K +$442K +32,115 New
KeyBank National Association
69
KeyBank National Association
Ohio
$576K +$68.8K +5,000 +19%
PCM
70
Prelude Capital Management
New York
$558K – – –
SCA
71
STALEY CAPITAL ADVISERS
Pennsylvania
$558K +$413K +30,000 New
TC
72
TFS Capital
Pennsylvania
$521K +$195K +14,144 +102%
SCA
73
SAC Capital Advisors
Connecticut
$472K +$350K +25,400 New
RA
74
Raffles Associates
New York
$465K – – –
LBC
75
Lawrence B. Cohen
$403K – – –
1 2
3
4 5

AMRI Hedge Fund Activity: Q1 2014 in Review

113 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Albany Molecular Research Inc (AMRI) for Q1 2014, worth a combined $515M — up 95% from $264M a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of AMRI and 23 opened new positions — a net loss of 5 holders — while 36 trimmed existing stakes and 37 added.

The largest buyer was Millennium Management, adding an estimated $13.3M. The largest seller was Wellington Management Group, cutting an estimated $15.9M.

  • 113 institutional investors held Albany Molecular Research Inc (AMRI) as of Q1 2014, down from 118 in Q4 2013.
  • Funds reported $515M of Albany Molecular Research Inc stock for Q1 2014, up 95% quarter-over-quarter.
  • 23 funds opened new Albany Molecular Research Inc positions in Q1 2014 and 28 closed out, a net change of -5 holders.
  • The largest Albany Molecular Research Inc buyer in Q1 2014 was Millennium Management, an estimated $13.3M added.
  • The largest Albany Molecular Research Inc seller in Q1 2014 was Wellington Management Group, an estimated $15.9M sold.

Based on aggregated 13F filings for Q1 2014.